✨ Free AI Report
Mycotopia Therapies, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Mycotopia Therapies, Inc.
Research Preview

Mycotopia Therapies, Inc.: Business Overview, Financials & Competitive Analysis

Data integrity issue: Mycotopia Therapies Inc. (OTC: TPIA) underwent a corporate transition to AIBiotics, Inc. (ticker AIBT) during 2022-2024. The company's current status, business operations, and strategic direction...

Analyst-debate audio for Mycotopia Therapies, Inc.

AskCyborg analysts argue the bull and bear cases for Mycotopia Therapies, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Mycotopia Therapies, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
Cyborg Score recalibrated: June 22, 2026
AI-Verified Research
30+ Page Report

Get the Latest Mycotopia Therapies, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Mycotopia Therapies, Inc. Overview

Pro stress-test →

Data integrity issue: Mycotopia Therapies Inc. (OTC: TPIA) underwent a corporate transition to AIBiotics, Inc. (ticker AIBT) during 2022-2024. The company's current status, business operations, and strategic direction as of June 2026 cannot be accurately determined from available sources.

Strategic Profile

Pro stress-test →

Historical profile (2021-2022): Mycotopia was a psychedelics-focused biopharma company pursuing natural and biosynthetic psilocybin development, supply agreements with Havn Life Sciences, and planned mergers with Ei.Ventures. However, this profile is obsolete due to corporate restructuring.

Competitive Landscape

Pro stress-test →

Historical competitors included Compass Pathways, MindMed, and Atai Life Sciences in psychedelics space. Current competitive positioning unknown due to corporate restructuring.

Industry Context

Mycotopia Therapies, Inc. operates in Unknown (formerly Psychedelics Development; now potentially AI/Robotics Wellness).

Key facts

Headquarters: Miami, US

What the analysts stress-tested

The top findings that survived the multi-agent debate for Mycotopia Therapies, Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Mycotopia Therapies, Inc. has a new material development →

Compare Mycotopia Therapies, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Mycotopia Therapies, Inc. operates in Unknown (formerly Psychedelics Development; now potentially AI/Robotics Wellness). See how the rest of the sector scores on the Cyborg framework.

Browse Unknown (formerly Psychedelics Development; now potentially AI/Robotics Wellness) research →
NEW · MCP server

Ask your AI assistant about Mycotopia Therapies, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Mycotopia Therapies, Inc. and its top competitor on Cyborg Score”
“What did Mycotopia Therapies, Inc. do this quarter?”
“Is Mycotopia Therapies, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Mycotopia Therapies, Inc. do?+
Data integrity issue: Mycotopia Therapies Inc. (OTC: TPIA) underwent a corporate transition to AIBiotics, Inc. (ticker AIBT) during 2022-2024. The company's current status, business operations, and strategic direction...
What is Mycotopia Therapies, Inc.'s Cyborg Score?+
The Cyborg Score is a 1-10 rating from the AskCyborg multi-agent analyst-debate framework. Recalibrated weekly across business, financials, leadership, competitive position, technology, marketing, and ESG dimensions.
Who are Mycotopia Therapies, Inc.'s main competitors?+
The full competitive landscape for Mycotopia Therapies, Inc. is in the AskCyborg report.
How can I get the full Mycotopia Therapies, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Mycotopia Therapies, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.